5DMJ
Structure of the extracellular domain of the CD40 in complex with 3H56-5 DAB
5DMJ の概要
エントリーDOI | 10.2210/pdb5dmj/pdb |
関連するPDBエントリー | 5DMI |
分子名称 | Tumor necrosis factor receptor superfamily member 5, 3H65-5 domain antibody (dAb), POTASSIUM ION, ... (4 entities in total) |
機能のキーワード | cell surface receptor, domain antibody, protein/protein interaction, immune system-signaling protein complex, immune system/signaling protein |
由来する生物種 | Homo sapiens (Human) 詳細 |
細胞内の位置 | Isoform I: Cell membrane; Single-pass type I membrane protein. Isoform II: Secreted: P25942 |
タンパク質・核酸の鎖数 | 6 |
化学式量合計 | 100189.06 |
構造登録者 | |
主引用文献 | Yamniuk, A.P.,Suri, A.,Krystek, S.R.,Tamura, J.,Ramamurthy, V.,Kuhn, R.,Carroll, K.,Fleener, C.,Ryseck, R.,Cheng, L.,An, Y.,Drew, P.,Grant, S.,Suchard, S.J.,Nadler, S.G.,Bryson, J.W.,Sheriff, S. Functional Antagonism of Human CD40 Achieved by Targeting a Unique Species-Specific Epitope. J.Mol.Biol., 428:2860-2879, 2016 Cited by PubMed Abstract: Current clinical anti-CD40 biologic agents include both antagonist molecules for the treatment of autoimmune diseases and agonist molecules for immuno-oncology, yet the relationship between CD40 epitope and these opposing biological outcomes is not well defined. This report describes the identification of potent antagonist domain antibodies (dAbs) that bind to a novel human CD40-specific epitope that is divergent in the CD40 of nonhuman primates. A similarly selected anti-cynomolgus CD40 dAb recognizing the homologous epitope is also a potent antagonist. Mutagenesis, biochemical, and X-ray crystallography studies demonstrate that the epitope is distinct from that of CD40 agonists. Both the human-specific and cynomolgus-specific molecules remain pure antagonists even when formatted as bivalent Fc-fusion proteins, making this an attractive therapeutic format for targeting hCD40 in autoimmune indications. PubMed: 27216500DOI: 10.1016/j.jmb.2016.05.014 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.79 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード